section name header

Pronunciation

VYE-ta-min E

Classifications

Therapeutic Classification: vitamins

Pharmacologic Classification: fat soluble vitamins

Indications

REMS


Action

  • Prevents the oxidation (antioxidant) of other substances.
  • Protects RBC membranes against hemolysis, especially in low-birth-weight neonates.
Therapeutic effects:
  • Prevention and treatment of deficiency in high-risk patients.

Pharmacokinetics

Absorption: 20–80% absorbed following oral administration. Absorption requires fat and bile salts.

Distribution: Widely distributed, stored in adipose tissue (4-yr supply).

Metabolism/Excretion: Metabolized by the liver, excreted in bile.

Half-Life: Unknown.

Time/Action Profile

ROUTEONSETPEAKDURATION
POunknownunknownunknown



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Seen primarily with large doses over long periods of time

Derm: rash

EENT: blurred vision

Endo: gonadal dysfunction

GI: cramps, diarrhea, nausea, NECROTIZING ENTEROCOLITIS (ORAL ADMINISTRATION IN LOW-BIRTH-WEIGHT INFANTS)

Neuro: fatigue, headache, weakness

Interactions

Drug-drug:

Drug-Natural Products:

Route/Dosage

Availability

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

alpha tocopherol, Amino-Opti-E, Aquasol E, E-200, E-400, E-1000, E-Complex-600, E-Vitamin, Liqui-E, Pheryl-E, Vita Plus E

Canadian Brand Names

Webber Vitamin E

Code

NDC Code